First in human intraarterial delivery of tislelizumab for the treatment of pMMR locally advanced rectal cancer: A single-arm, open label, phase II clinical trial

Authors

Nan Dai (ORCID: https://orcid.org/0000-0001-9434-5621)
Yan Feng (ORCID: https://orcid.org/0000-0002-3906-6539)
Weina Yang
Dong Wang (ORCID: https://orcid.org/0000-0001-6585-2704)
Mengxia Li (ORCID: https://orcid.org/0000-0003-4443-740X)
Xuemei Li (ORCID: https://orcid.org/0000-0001-5391-8403)
Chuan Chen (ORCID: https://orcid.org/0000-0003-0047-9560)
Yuxin Yang (ORCID: https://orcid.org/0000-0001-7398-7473)
He Xiao (ORCID: https://orcid.org/0000-0003-2298-1121)
Chunxue Li (ORCID: https://orcid.org/0000-0002-6668-173X)
Jiamin Luo (ORCID: https://orcid.org/0000-0003-2829-1914)
Chengyuan Qian

Institutions

Army Medical University (CN)
Chongqing University (CN)
Daping Hospital (CN)
Jiangjin Central Hospital (CN)

Publication Details

Journal: Translational Oncology
Published: 2024-10-13
DOI: https://doi.org/10.1016/j.tranon.2024.102154
Citations: 1
Primary Topic: Colorectal Cancer Surgical Treatments
Type: article
Field-Weighted Citation Impact: 0.28

Funders

Army Medical University

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

First in human intraarterial delivery of tislelizumab for the treatment of pMMR locally advanced rectal cancer: A single-arm, open label, phase II clinical trial

Nan Dai, Yan Feng, Weina Yang, Dong Wang et al.

Oct 13, 2024

1 citations

Translational Oncology

Colorectal Cancer Surgical Treatments

0.28

article

First in human intraarterial delivery of tislelizumab for the treatment of pMMR locally advanced rectal cancer: A single-arm, open label, phase II clinical trial

Nan Dai, Yan Feng, Weina Yang, Dong Wang, Mengxia Li, Xuemei Li, Chuan Chen, Yuxin Yang, He Xiao, Chunxue Li, Jiamin Luo, Chengyuan Qian

October 13, 2024article en

1 citations

Abstract

No abstract available for this paper.

Translational OncologyVol. 50

Army Medical University (CN), Chongqing University (CN), Daping Hospital (CN), Jiangjin Central Hospital (CN)

Army Medical University

Good health and well-being

Openalex Percentile: Top 35%

Colorectal Cancer Surgical Treatments

0.28

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

First in human intraarterial delivery of tislelizumab for the treatment of pMMR locally advanced rectal cancer: A single-arm, open label, phase II clinical trial — Nan Dai, Yan Feng, et al. · Translational Oncology (2024) | TGRS Research Map | TGRS